Position in EPRX
as of Mar 31, 2026
· filed Apr 27, 2026
Position Value
$79,640
-$3,410 QoQ
Shares Held
11,000
0.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#44
of 54 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in EPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TCI Wealth Advisors, Inc. holds $350,273 across 2 Biotechnology names. EPRX ranks #2 (22.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
517 | $270,633 | |
| 2 | EPRX |
Eupraxia Pharmaceuticals Inc.
This page
|
11,000 | $79,640 |
All Filings in EPRX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $79,640 | 11,000 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $83,050 | 11,000 | Shares | Sole | 2026-02-02 | |
| 2025-09-30 | $64,900 | 11,000 | Shares | Sole | 2025-10-14 | |
| No filing history on record for this holder in this stock. | ||||||